🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPharmacology & MechanismsGLP-1/GIP receptor co-agonism — anyone have experience? Page 4

GLP-1/GIP receptor co-agonism — anyone have experience?

Dr.NephBHM_UK Thu, Apr 2, 2026 at 2:36 AM 36 replies 1,378 viewsPage 4 of 8
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Apr 2, 2026 at 8:16 AM#16

Just wanted to say — for anyone reading this GLP-1/GIP receptor thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

30 6VendorMark, COA_Karl, MikeFit_NJ and 27 others
Reply Quote Save Share Report
nick_newbie
New Member
18
56
Jun 2026
Virginia
Online
Apr 2, 2026 at 8:33 AM#17

Dr.NephBHM_UK's experience with GLP-1/GIP receptor resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I titrated faster. But the overall trajectory has been remarkably similar. Down 64 lbs in 9 months.

One thing I would add that Dr.NephBHM_UK did not mention: the relationship with food fundamentally changed.

16 10dan_philly, MeganSA_TX, LarryQC_SD and 13 others
Reply Quote Save Share Report
RunnerRach
Member
467
2,123
Aug 2024
Boston, MA
Apr 2, 2026 at 8:50 AM#18

Saving this for reference. Quality thread.

47 2Dr.RaviCardio, jennifer_SEA, tyler_CSCS and 44 others
Reply Quote Save Share Report
Dr.GutHealth
Senior Member
1,456
7,890
Mar 2024
Minnesota
Apr 2, 2026 at 9:07 AM#19

As a healthcare provider, I want to add some clinical context to this discussion on GLP-1/GIP receptor co-agonism anyone.

Building on what Dr.NephBHM_UK said — the evidence base here is well-established. The key publications to reference are from the SURMOUNT program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
Last edited: Apr 2, 2026 at 2:07 PM
41 12Dr.RaviCardio, jennifer_SEA, tyler_CSCS and 38 others
Reply Quote Save Share Report
Dr.SurgeonPGH
Senior Member
1,345
6,789
Mar 2024
Pittsburgh, PA
Apr 2, 2026 at 9:24 AM#20

Subscribing to this thread. GLP-1/GIP receptor is exactly what I've been researching. 🙏

Last edited: Apr 2, 2026 at 12:24 PM
36 5B12Beth, RickReta_CO, PharmHunterJen and 33 others
Reply Quote Save Share Report

Similar Threads

GLP-1R desensitization — β-arrestin-mediated internalization18 replies
Biased agonism at GLP-1R — Gs vs β-arrestin signaling balance13 replies
Semaglutide albumin binding and the C-18 fatty acid linker17 replies
GIP receptor pharmacology — why GIP agonism enhances GLP-113 replies
Glucagon receptor signaling — hepatic glycogenolysis and lipolysis16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register